219 related articles for article (PubMed ID: 15571673)
1. Involvement of kappa-opioid receptors and sigma receptors in memory function demonstrated using an antisense strategy.
Hiramatsu M; Hoshino T
Brain Res; 2004 Dec; 1030(2):247-55. PubMed ID: 15571673
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of the ameliorating effect on short-term memory impairment and antinociceptive effect of KT-90 in mice.
Hiramatsu M; Hoshino T; Kanematsu K
Behav Brain Res; 2005 May; 160(2):374-81. PubMed ID: 15863234
[TBL] [Abstract][Full Text] [Related]
3. Effects of U-50,488H on scopolamine-, mecamylamine- and dizocilpine-induced learning and memory impairment in rats.
Hiramatsu M; Murasawa H; Nabeshima T; Kameyama T
J Pharmacol Exp Ther; 1998 Mar; 284(3):858-67. PubMed ID: 9495843
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of the ameliorating effect on learning and memory impairment and antinociceptive effect of KT-95 in mice.
Hiramatsu M; Mizuno N; Kanematsu K
Behav Brain Res; 2006 Feb; 167(2):219-25. PubMed ID: 16223533
[TBL] [Abstract][Full Text] [Related]
5. Improvement of memory impairment by (+)- and (-)-pentazocine via sigma, but not kappa opioid receptors.
Hiramatsu M; Hoshino T
Brain Res; 2005 Sep; 1057(1-2):72-80. PubMed ID: 16125682
[TBL] [Abstract][Full Text] [Related]
6. Involvement of kappa-opioid and sigma receptors in short-term memory in mice.
Hiramatsu M; Hoshino T; Kameyama T; Nabeshima T
Eur J Pharmacol; 2002 Oct; 453(1):91-8. PubMed ID: 12393064
[TBL] [Abstract][Full Text] [Related]
7. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors.
Khotib J; Narita M; Suzuki M; Yajima Y; Suzuki T
Neuropharmacology; 2004 Mar; 46(4):531-40. PubMed ID: 14975677
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection and functional recovery conferred by administration of kappa- and delta 1-opioid agonists in a rat model of global ischemia.
Charron C; Messier C; Plamondon H
Physiol Behav; 2008 Feb; 93(3):502-11. PubMed ID: 18031772
[TBL] [Abstract][Full Text] [Related]
9. Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H.
Ho BY; Takemori AE
J Pharmacol Exp Ther; 1989 Aug; 250(2):508-14. PubMed ID: 2547935
[TBL] [Abstract][Full Text] [Related]
10. Selective antagonism of opioid analgesia by a sigma system.
Chien CC; Pasternak GW
J Pharmacol Exp Ther; 1994 Dec; 271(3):1583-90. PubMed ID: 7996472
[TBL] [Abstract][Full Text] [Related]
11. Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the mu-selective opioid receptor agonist DAMGO in mice.
Itoh J; Ukai M; Kameyama T
J Pharmacol Exp Ther; 1994 Apr; 269(1):15-21. PubMed ID: 7909556
[TBL] [Abstract][Full Text] [Related]
12. Contralateral, ipsilateral and bilateral treatments with the kappa-opioid receptor agonist U-50,488H in mononeuropathic rats.
Bileviciute-Ljungar I; Spetea M
Eur J Pharmacol; 2004 Jun; 494(2-3):139-46. PubMed ID: 15212967
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent antagonism and potentiation of nitrous oxide antinociception by naloxone in mice.
Quock RM; Curtis BA; Reynolds BJ; Mueller JL
J Pharmacol Exp Ther; 1993 Oct; 267(1):117-22. PubMed ID: 8229738
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive actions of dexmedetomidine and the kappa-opioid agonist U-50,488H against noxious thermal, mechanical and inflammatory stimuli.
Idänpään-Heikkilä JJ; Kalso EA; Seppälä T
J Pharmacol Exp Ther; 1994 Dec; 271(3):1306-13. PubMed ID: 7996439
[TBL] [Abstract][Full Text] [Related]
15. Modulation of anxiety-related behaviors by mu- and kappa-opioid receptor agonists depends on the social status of mice.
Kudryavtseva NN; Gerrits MA; Avgustinovich DF; Tenditnik MV; Van Ree JM
Peptides; 2004 Aug; 25(8):1355-63. PubMed ID: 15350704
[TBL] [Abstract][Full Text] [Related]
16. Roles of kappa-opioid receptor agonists in learning and memory impairment in animal models.
Hiramatsu M; Kameyama T
Methods Find Exp Clin Pharmacol; 1998 Sep; 20(7):595-9. PubMed ID: 9819804
[TBL] [Abstract][Full Text] [Related]
17. dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice.
Wu HE; Sun HS; Terashivili M; Schwasinger E; Sora I; Hall FS; Uhl GR; Tseng LF
Eur J Pharmacol; 2006 Feb; 531(1-3):103-7. PubMed ID: 16445907
[TBL] [Abstract][Full Text] [Related]
18. A new sigma ligand, (+/-)-PPCC, antagonizes kappa opioid receptor-mediated antinociceptive effect.
Prezzavento O; Parenti C; Marrazzo A; Ronsisvalle S; Vittorio F; Aricò G; Scoto GM; Ronsisvalle G
Life Sci; 2008 Mar; 82(11-12):549-53. PubMed ID: 18261749
[TBL] [Abstract][Full Text] [Related]
19. Anxiety and ethanol consumption in victorious and defeated mice; effect of kappa-opioid receptor activation.
Kudryavtseva N; Gerrits MA; Avgustinovich DF; Tenditnik MV; Van Ree JM
Eur Neuropsychopharmacol; 2006 Oct; 16(7):504-11. PubMed ID: 16524701
[TBL] [Abstract][Full Text] [Related]
20. Alpha 7-type nicotinic acetylcholine receptor and prodynorphin mRNA expression after administration of (-)-nicotine and U-50,488H in beta-amyloid peptide (25-35)-treated mice.
Hiramatsu M; Watanabe M; Baba S; Kojima R; Nabeshima T
Ann N Y Acad Sci; 2004 Oct; 1025():508-14. PubMed ID: 15542756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]